This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Yc Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hyo Sang Jo - Innovator in Liver Disease Treatment
Introduction
Hyo Sang Jo is an accomplished inventor based in Hwaseong-si, Gyeonggi-do, South Korea. She is currently associated with Hanmi Pharmaceutical Co., Ltd. Despite having no granted patents to her name, her work in the field of therapeutic applications is noteworthy.
Latest Patent Applications
Hyo Sang Jo's recent patent application focuses on the therapeutic use of a glucagon derivative or a conjugate thereof for liver disease. The application details new therapeutic uses of this glucagon derivative, represented by the formula: Y-X2-QGTF-X7-SDYSKY-X14-D-X16-X17-R-X19-X20-X21-FVQWLMNT-X30 (General Formula 1, SEQ ID NO: 46). This innovative approach aims to prevent or treat liver diseases, showcasing her commitment to advancing medical science.
Conclusion
Hyo Sang Jo's contributions to the field of liver disease treatment highlight her potential as an inventor. Her ongoing research and applications may pave the way for significant advancements in therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile